Correlation Between Merck and 17252MAQ3
Specify exactly 2 symbols:
By analyzing existing cross correlation between Merck Company and CTAS 4 01 MAY 32, you can compare the effects of market volatilities on Merck and 17252MAQ3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of 17252MAQ3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and 17252MAQ3.
Diversification Opportunities for Merck and 17252MAQ3
Very poor diversification
The 3 months correlation between Merck and 17252MAQ3 is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and CTAS 4 01 MAY 32 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CTAS 4 01 and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with 17252MAQ3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CTAS 4 01 has no effect on the direction of Merck i.e., Merck and 17252MAQ3 go up and down completely randomly.
Pair Corralation between Merck and 17252MAQ3
Considering the 90-day investment horizon Merck Company is expected to generate 1.7 times more return on investment than 17252MAQ3. However, Merck is 1.7 times more volatile than CTAS 4 01 MAY 32. It trades about 0.0 of its potential returns per unit of risk. CTAS 4 01 MAY 32 is currently generating about -0.01 per unit of risk. If you would invest 10,517 in Merck Company on September 3, 2024 and sell it today you would lose (353.00) from holding Merck Company or give up 3.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 83.64% |
| Values | Daily Returns |
Merck Company vs. CTAS 4 01 MAY 32
Performance |
| Timeline |
| Merck Company |
| CTAS 4 01 |
Merck and 17252MAQ3 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and 17252MAQ3
The main advantage of trading using opposite Merck and 17252MAQ3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, 17252MAQ3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 17252MAQ3 will offset losses from the drop in 17252MAQ3's long position.| Merck vs. Pfizer Inc | Merck vs. Johnson Johnson | Merck vs. Highway Holdings Limited | Merck vs. QCR Holdings |
| 17252MAQ3 vs. Electrovaya Common Shares | 17252MAQ3 vs. Ryanair Holdings PLC | 17252MAQ3 vs. Copa Holdings SA | 17252MAQ3 vs. Nok Airlines Public |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |